Home  
Shop Subscribe Contact us About us
---- News Categories -----        

LATEST NEWS
Chemicals
Children's health
Climate change
Diet
Energy sources

Fertility
Food Industry
GM crops
Illnesses
Lifestyle

Transport
Vaccination
Women's health
Workplace health
TOP TWENTY
Subscribe/Renew

WOMEN'S HEALTH
breast cancer

Killer bras?

Carrots and breast cancer

Having first baby before 22
best protection


Return to WOMEN'S HEALTH
subject selector

Go to MEN'S HEALTH
subject selector


Coffee may boost
oestrogen levels


Breast cancer prevention
at 8p a day

Surgery may spread
cancer


Dairy-free diet for
breast cancer


Breast cancer and sunlight

Genetic susceptibility
exaggerated


Breast cancer halted
HRT study


Nuclear stitch up
in breast cancer clusters


Mass screening bad
for over 50s


Night shifts and breast cancer

Over 50s obesity doubled
breast cancer risk


Obesity in pregnancy
cancer risk


Overeating, exercise
and breast cancer


Tamoxifen not to be used
as a preventative


Tamoxifen and
endometrial cancer


Tamoxifen may lead to
new breast tumours


Prolonged use of the Pill can
double risk of cancer

 
Mass screening bad for over-50s
Mammograms do not significantly reduce deaths from breast cancer and should be abandoned. So concluded a 1999 Danish review of research on the safety and accuracy of mammogram screening. [1]

The review's methodology was widely criticised, so it was rerun using a method designed by the Cochrane Collaboration, an international group whose evaluations of medical treatments are highly respected. The re-run came to the same conclusions.

The re-run by Ole Olsen & Peter Gotzsche from the Nordic Cochrane centre in Copenhagen (Denmark), routine breast cancer screening of women over 50 did not reduce deaths. It might actually do harm, they suggested, because they often led to surgery to remove tumours, some of which are so slow growing that they would never have developed into cancer in the women’s lifetimes. They found that women who had been screened had suffered a 20% above average level of mastectomy and a 30% above average level of combined mastectomy and tumour operations.

This time it was the Cochrane Collaboration themselves who objected. They refused to publish it unless changes are made. In response, The Lancet took the unusual step of publishing the original study (20.10.01) accompanied by a blistering comment from editor Dr. Richard Horton condemning Cochrane for interference that "eroded academic freedom".

[1] Gotzsche,PC and Olsen,O. Lancet 2000;355(9198):129-34

(8610) Olsen O, Gotzsche PC. Cochrane Database Syst Rev. 2001;(4):CD001877